HEADER TRANSCRIPTION/INHIBITOR 01-MAR-21 7LWG TITLE CRYSTAL STRUCTURE OF THE BCL6 BTB DOMAIN IN COMPLEX WITH OICR-12694 COMPND MOL_ID: 1; COMPND 2 MOLECULE: B-CELL LYMPHOMA 6 PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: BTB DOMAIN, RESIDUES 5-129; COMPND 5 SYNONYM: BCL-6,B-CELL LYMPHOMA 5 PROTEIN,BCL-5,PROTEIN LAZ-3,ZINC COMPND 6 FINGER AND BTB DOMAIN-CONTAINING PROTEIN 27,ZINC FINGER PROTEIN 51; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BCL6, BCL5, LAZ3, ZBTB27, ZNF51; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI 'BL21-GOLD(DE3)PLYSS AG'; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 866768 KEYWDS IMMUNITY, INFLAMMATORY RESPONSE, TRANSCRIPTION REPRESSOR, KEYWDS 2 TRANSCRIPTION-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR D.A.KUNTZ,G.G.PRIVE REVDAT 4 25-OCT-23 7LWG 1 REMARK REVDAT 3 01-MAR-23 7LWG 1 JRNL REVDAT 2 25-JAN-23 7LWG 1 JRNL REVDAT 1 09-MAR-22 7LWG 0 JRNL AUTH A.MAMAI,A.M.CHAU,B.J.WILSON,I.D.WATSON,B.B.JOSEPH, JRNL AUTH 2 P.R.SUBRAMANIAN,M.M.MORSHED,J.A.MORIN,M.A.PRAKESCH,T.LU, JRNL AUTH 3 P.CONNOLLY,D.A.KUNTZ,N.C.POMROY,G.PODA,K.NGUYEN,R.MARCELLUS, JRNL AUTH 4 G.STRATHDEE,B.THERIAULT,R.SUBRAMANIAM,M.MOHAMMED,A.ABIBI, JRNL AUTH 5 M.CHAN,J.WINSTON,T.KIYOTA,E.UNDZYS,A.AMAN,N.AUSTIN, JRNL AUTH 6 M.DU JARDIN,K.PACKMAN,U.PHILLIPPAR,R.ATTAR,J.EDWARDS, JRNL AUTH 7 J.O'MEARA,D.E.UEHLING,R.AL-AWAR,G.G.PRIVE,M.B.ISAAC JRNL TITL DISCOVERY OF OICR12694: A NOVEL, POTENT, SELECTIVE, AND JRNL TITL 2 ORALLY BIOAVAILABLE BCL6 BTB INHIBITOR. JRNL REF ACS MED.CHEM.LETT. V. 14 199 2023 JRNL REFN ISSN 1948-5875 JRNL PMID 36793435 JRNL DOI 10.1021/ACSMEDCHEMLETT.2C00502 REMARK 2 REMARK 2 RESOLUTION. 1.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.18.2_3874: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 53.11 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.960 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.1 REMARK 3 NUMBER OF REFLECTIONS : 57180 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.146 REMARK 3 R VALUE (WORKING SET) : 0.144 REMARK 3 FREE R VALUE : 0.184 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.990 REMARK 3 FREE R VALUE TEST SET COUNT : 2853 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 53.1100 - 3.5300 1.00 2872 138 0.1799 0.2055 REMARK 3 2 3.5300 - 2.8000 0.99 2873 126 0.1437 0.1786 REMARK 3 3 2.8000 - 2.4500 0.99 2800 136 0.1236 0.1487 REMARK 3 4 2.4500 - 2.2200 0.99 2786 157 0.1133 0.1506 REMARK 3 5 2.2200 - 2.0600 0.98 2797 159 0.1045 0.1491 REMARK 3 6 2.0600 - 1.9400 0.98 2740 156 0.1107 0.1568 REMARK 3 7 1.9400 - 1.8400 0.98 2771 134 0.1096 0.1575 REMARK 3 8 1.8400 - 1.7600 0.97 2712 133 0.1107 0.1450 REMARK 3 9 1.7600 - 1.7000 0.97 2720 162 0.1143 0.1631 REMARK 3 10 1.7000 - 1.6400 0.96 2720 169 0.1215 0.1818 REMARK 3 11 1.6400 - 1.5900 0.96 2671 155 0.1281 0.1672 REMARK 3 12 1.5900 - 1.5400 0.95 2689 154 0.1371 0.2092 REMARK 3 13 1.5400 - 1.5000 0.95 2687 130 0.1506 0.2044 REMARK 3 14 1.5000 - 1.4600 0.95 2715 121 0.1593 0.2161 REMARK 3 15 1.4600 - 1.4300 0.94 2645 144 0.1733 0.2330 REMARK 3 16 1.4300 - 1.4000 0.93 2646 141 0.1921 0.2269 REMARK 3 17 1.4000 - 1.3700 0.93 2597 136 0.2045 0.2556 REMARK 3 18 1.3700 - 1.3500 0.94 2633 152 0.2176 0.2621 REMARK 3 19 1.3500 - 1.3200 0.93 2592 111 0.2396 0.3096 REMARK 3 20 1.3200 - 1.3000 0.93 2661 139 0.2645 0.3403 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.140 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 19.660 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 10.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.010 2177 REMARK 3 ANGLE : 1.261 2968 REMARK 3 CHIRALITY : 0.076 335 REMARK 3 PLANARITY : 0.007 371 REMARK 3 DIHEDRAL : 25.479 822 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7LWG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-MAR-21. REMARK 100 THE DEPOSITION ID IS D_1000255133. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-FEB-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 57693 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.300 REMARK 200 RESOLUTION RANGE LOW (A) : 53.110 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.0 REMARK 200 DATA REDUNDANCY : 4.400 REMARK 200 R MERGE (I) : 0.06600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.32 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.5 REMARK 200 DATA REDUNDANCY IN SHELL : 4.20 REMARK 200 R MERGE FOR SHELL (I) : 0.43200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3LB7 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.15 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10% PEG 6000, 0.1M ACETATE:MES BUFFER REMARK 280 PH 5.2, 10% DMSO, 50 MM CACL2 WITH MICROSEEDING, MICROBATCH, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 36.46950 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4510 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12530 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -28.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 5 REMARK 465 ASP A 6 REMARK 465 GLU A 129 REMARK 465 ALA B 5 REMARK 465 ASP B 6 REMARK 465 SER B 7 REMARK 465 GLU B 129 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 94 CZ NH1 NH2 REMARK 470 ARG A 98 CZ NH1 NH2 REMARK 470 LYS A 123 CE NZ REMARK 470 ARG B 40 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 39 -119.75 53.11 REMARK 500 GLN A 113 62.10 62.92 REMARK 500 SER B 39 -116.68 65.46 REMARK 500 GLN B 113 61.66 62.80 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue YN7 A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue YN7 B 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 202 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7LWE RELATED DB: PDB REMARK 900 RELATED ID: 7LWF RELATED DB: PDB DBREF 7LWG A 5 129 UNP P41182 BCL6_HUMAN 5 129 DBREF 7LWG B 5 129 UNP P41182 BCL6_HUMAN 5 129 SEQADV 7LWG GLN A 8 UNP P41182 CYS 8 ENGINEERED MUTATION SEQADV 7LWG ARG A 67 UNP P41182 CYS 67 ENGINEERED MUTATION SEQADV 7LWG ASN A 84 UNP P41182 CYS 84 ENGINEERED MUTATION SEQADV 7LWG GLN B 8 UNP P41182 CYS 8 ENGINEERED MUTATION SEQADV 7LWG ARG B 67 UNP P41182 CYS 67 ENGINEERED MUTATION SEQADV 7LWG ASN B 84 UNP P41182 CYS 84 ENGINEERED MUTATION SEQRES 1 A 125 ALA ASP SER GLN ILE GLN PHE THR ARG HIS ALA SER ASP SEQRES 2 A 125 VAL LEU LEU ASN LEU ASN ARG LEU ARG SER ARG ASP ILE SEQRES 3 A 125 LEU THR ASP VAL VAL ILE VAL VAL SER ARG GLU GLN PHE SEQRES 4 A 125 ARG ALA HIS LYS THR VAL LEU MET ALA CYS SER GLY LEU SEQRES 5 A 125 PHE TYR SER ILE PHE THR ASP GLN LEU LYS ARG ASN LEU SEQRES 6 A 125 SER VAL ILE ASN LEU ASP PRO GLU ILE ASN PRO GLU GLY SEQRES 7 A 125 PHE ASN ILE LEU LEU ASP PHE MET TYR THR SER ARG LEU SEQRES 8 A 125 ASN LEU ARG GLU GLY ASN ILE MET ALA VAL MET ALA THR SEQRES 9 A 125 ALA MET TYR LEU GLN MET GLU HIS VAL VAL ASP THR CYS SEQRES 10 A 125 ARG LYS PHE ILE LYS ALA SER GLU SEQRES 1 B 125 ALA ASP SER GLN ILE GLN PHE THR ARG HIS ALA SER ASP SEQRES 2 B 125 VAL LEU LEU ASN LEU ASN ARG LEU ARG SER ARG ASP ILE SEQRES 3 B 125 LEU THR ASP VAL VAL ILE VAL VAL SER ARG GLU GLN PHE SEQRES 4 B 125 ARG ALA HIS LYS THR VAL LEU MET ALA CYS SER GLY LEU SEQRES 5 B 125 PHE TYR SER ILE PHE THR ASP GLN LEU LYS ARG ASN LEU SEQRES 6 B 125 SER VAL ILE ASN LEU ASP PRO GLU ILE ASN PRO GLU GLY SEQRES 7 B 125 PHE ASN ILE LEU LEU ASP PHE MET TYR THR SER ARG LEU SEQRES 8 B 125 ASN LEU ARG GLU GLY ASN ILE MET ALA VAL MET ALA THR SEQRES 9 B 125 ALA MET TYR LEU GLN MET GLU HIS VAL VAL ASP THR CYS SEQRES 10 B 125 ARG LYS PHE ILE LYS ALA SER GLU HET YN7 A 201 73 HET GOL A 202 14 HET UNX A 203 1 HET UNX A 204 1 HET UNX A 205 1 HET YN7 B 201 73 HET GOL B 202 14 HET UNX B 203 1 HETNAM YN7 5-{(5S)-1-[2-({3-CHLORO-6-[(2S)-2,4-DIMETHYLPIPERAZIN- HETNAM 2 YN7 1-YL]-2-FLUOROPYRIDIN-4-YL}AMINO)-2-OXOETHYL]-4-OXO-4, HETNAM 3 YN7 6,7,8-TETRAHYDRO-1H-DIPYRROLO[1,2-A:2',3'-D]PYRIMIDIN- HETNAM 4 YN7 3-YL}-3,4-DIFLUORO-2-HYDROXYBENZAMIDE HETNAM GOL GLYCEROL HETNAM UNX UNKNOWN ATOM OR ION HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 YN7 2(C29 H28 CL F3 N8 O4) FORMUL 4 GOL 2(C3 H8 O3) FORMUL 5 UNX 4(X) FORMUL 11 HOH *213(H2 O) HELIX 1 AA1 ARG A 13 ARG A 28 1 16 HELIX 2 AA2 HIS A 46 SER A 54 1 9 HELIX 3 AA3 SER A 54 THR A 62 1 9 HELIX 4 AA4 ASN A 79 SER A 93 1 15 HELIX 5 AA5 ASN A 101 GLN A 113 1 13 HELIX 6 AA6 MET A 114 SER A 128 1 15 HELIX 7 AA7 ARG B 13 ARG B 28 1 16 HELIX 8 AA8 HIS B 46 SER B 54 1 9 HELIX 9 AA9 SER B 54 ASP B 63 1 10 HELIX 10 AB1 ASN B 79 SER B 93 1 15 HELIX 11 AB2 ASN B 101 GLN B 113 1 13 HELIX 12 AB3 MET B 114 SER B 128 1 15 SHEET 1 AA1 2 ILE A 9 GLN A 10 0 SHEET 2 AA1 2 ARG B 94 LEU B 95 -1 O LEU B 95 N ILE A 9 SHEET 1 AA2 3 GLU A 41 ALA A 45 0 SHEET 2 AA2 3 VAL A 34 VAL A 38 -1 N ILE A 36 O PHE A 43 SHEET 3 AA2 3 VAL A 71 ASN A 73 1 O ILE A 72 N VAL A 37 SHEET 1 AA3 2 ARG A 94 LEU A 95 0 SHEET 2 AA3 2 ILE B 9 GLN B 10 -1 O ILE B 9 N LEU A 95 SHEET 1 AA4 3 GLU B 41 ALA B 45 0 SHEET 2 AA4 3 VAL B 34 VAL B 38 -1 N ILE B 36 O PHE B 43 SHEET 3 AA4 3 VAL B 71 ASN B 73 1 O ILE B 72 N VAL B 37 SITE 1 AC1 24 GLU A 41 MET A 51 ALA A 52 CYS A 53 SITE 2 AC1 24 SER A 54 GLY A 55 TYR A 58 PRO A 80 SITE 3 AC1 24 GLU A 81 ASN A 84 PHE A 89 GLN A 113 SITE 4 AC1 24 MET A 114 GLU A 115 HIS A 116 VAL A 117 SITE 5 AC1 24 HOH A 314 HOH A 349 HIS B 14 ASP B 17 SITE 6 AC1 24 ASN B 21 ARG B 24 LEU B 25 HOH B 317 SITE 1 AC2 6 ASP A 33 LYS A 47 THR A 48 ASP B 33 SITE 2 AC2 6 LYS B 47 THR B 48 SITE 1 AC3 25 PHE A 11 HIS A 14 ASP A 17 ASN A 21 SITE 2 AC3 25 ARG A 24 LEU A 25 ARG A 28 MET B 51 SITE 3 AC3 25 ALA B 52 CYS B 53 SER B 54 GLY B 55 SITE 4 AC3 25 TYR B 58 GLU B 81 ASN B 84 PHE B 89 SITE 5 AC3 25 ASN B 96 GLN B 113 MET B 114 GLU B 115 SITE 6 AC3 25 HIS B 116 VAL B 117 GOL B 202 HOH B 324 SITE 7 AC3 25 HOH B 367 SITE 1 AC4 5 ASP A 17 GLU B 115 HIS B 116 YN7 B 201 SITE 2 AC4 5 HOH B 331 CRYST1 31.786 72.939 55.336 90.00 106.32 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.031460 0.000000 0.009210 0.00000 SCALE2 0.000000 0.013710 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018830 0.00000